 Blood and tumor tissue samples are collected periodically to evaluate secreted protein acidic and rich in cysteine SPARC content of tumor tissue by immunohistochemistry and to explore the impact of therapy on immune homeostasis. Samples are also analyzed by immunoenzyme techniques for angiogenesis markers. 